Search results for "Giant cell arteriti"

showing 10 items of 32 documents

Giant cell arteritis associated with chronic active Epstein-Barr virus infection

2013

Giant cell arteritis is an inflammatory vasculopathy that preferentially affects medium-sized and large arteries. A viral cause has been suspected but not confirmed in polymyalgia rheumatica and giant-cell arteritis. We report the case of a 81-year-old female who suffered from chronic active Epstein-Barr virus infection and developed giant cell temporal arteritis.

musculoskeletal diseaseslcsh:Internal medicineSettore MED/07 - Microbiologia E Microbiologia ClinicaEpstein-Barr Virus InfectionsHerpesvirus 4 HumanBiopsyGiant Cell Arteritischronic active EBV infection (CAEBV-infection)lcsh:MedicineVirusPolymyalgia rheumaticaRheumatologyChronic Active Epstein-Barr VirusBiopsyMedicineHumansArteritislcsh:RC31-1245Aged 80 and overmedicine.diagnostic_testGiant cell arteritis (GCA) Epstein Barr virus (EBV) chronic active EBV infection (CAEBV-infection)business.industryChronic Activelcsh:Rmedicine.diseaseTemporal ArteriesGiant cell arteritisGiant cellGiant cell arteritis (GCA)ImmunologyChronic DiseaseDNA ViralFemaleGiant cell arteritis (GCA) Epstein Barr virus (EBV) chronic active EBV infection (CAEBV-infection).businessEpstein Barr virus (EBV)
researchProduct

Rationale and evidence on the use of tocilizumab in COVID-19: a systematic review

2020

Abstract Background Tocilizumab is an IL-6 receptor-blocking agent proposed for the treatment of severe COVID-19. The aim of this systematic review was to describe the rationale for the use of tocilizumab for the treatment of COVID-19 and to summarize the available evidence regarding its efficacy and safety. Methods MEDLINE, PubMed, EMBASE, pre-print repositories (bioRxiv and medRxiv) and two trial Registries were searched for studies on the use of tocilizumab in COVID-19 or SARS-CoV-2 infection, viral pneumonia, and/or sepsis until 20th June 2020. Results We identified 3 indirect pre-clinical studies and 28 clinical studies including 5776 patients with COVID-19 (13 with a comparison group,…

Coronavirus COVID-19 Pneumonia SARS-CoV-2 TocilizumabGCA Giant cell arteritispJIA Pediatric juvenile idiopathic arthritislaw.inventionchemistry.chemical_compound0302 clinical medicineRandomized controlled triallawMedicine030212 general & internal medicineClinical efficacyCPAP Continuous positive airway pressureCOVID-19 Coronavirus disease 2019IDSA Infectious Diseases Society of AmericaRA Rheumatoid arthritisTocilizumabIMV Invasive mechanical ventilationsJIA Juvenile idiopathic arthritisAIFA Agenzia Italiana del FarmacoPulmonary and Respiratory Medicinemedicine.medical_specialtyCoronavirus disease 2019 (COVID-19)Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)MEDLINEAntibodies Monoclonal HumanizedNIH U.S. National Institutes of HealthArticleWHO World Health OrganizationSIMIT Italian Society of Infectious and Tropical disease03 medical and health sciencesTocilizumabARDS Acute respiratory distress syndromeAnimalsHumansIn patientIntensive care medicineTocilizumab ; COVID-19 ; Pneumonia ; SARS-CoV-2 ; Coronaviruslcsh:RC705-779business.industryCRS CAR-T cell-induced cytokine release syndromeInterleukin-6SARS-CoV-2NIV Noninvasive mechanical ventilationTNF Tumor necrosis factorCOVID-19Pneumonialcsh:Diseases of the respiratory systemCOVID-19 Drug TreatmentClinical trialCoronavirus030228 respiratory systemchemistrybusinessICTRP International Clinical Trials Registry PlatformPulmonology
researchProduct

Diseases of the vertebral arteries.

1990

Case reports and postmortem neuropathological findings of a wide spectrum of diseases affecting the vertebral arteries, in particular vasculitis, traumatic lesions, degenerative changes and congenital abnormalities, are discussed.

AdultMaleVasculitisPathologymedicine.medical_specialtySystemic diseaseVertebral arteryAneurysmmedicine.arteryMedicineHumansChiropractic manipulationVertebral ArteryAgedAged 80 and overbusiness.industryGeneral MedicineMiddle Agedmedicine.diseaseGiant cell arteritisSurgeryFemalesense organsNeurology (clinical)NeurosurgerybusinessVasculitisNeurosurgical review
researchProduct

Recurrent strokes associated with uncontrollable giant cell arteritis

2016

International audience

030203 arthritis & rheumatologymedicine.medical_specialtybusiness.industry[SDV.NEU.NB]Life Sciences [q-bio]/Neurons and Cognition [q-bio.NC]/Neurobiologymedicine.disease03 medical and health sciencesGiant cell arteritis0302 clinical medicineNeurologyRecurrent stroke[ SDV.NEU.NB ] Life Sciences [q-bio]/Neurons and Cognition [q-bio.NC]/NeurobiologyStrokesmedicineNeurology (clinical)Radiologybusiness030217 neurology & neurosurgeryComputingMilieux_MISCELLANEOUSGiant cell arteritis
researchProduct

Orthopantomography contribution to prevent isquemic stroke.

2014

Objectives: The ortopantomography (OPG) can be a valuable way for an early detection of calcified atheroma plaques, thus contributing for a preliminary stroke risk evaluation. The study looks for the existence of calcified atheroma plates through the use of OPG, comparing the results with the stenosis percentage found through eco-doppler. It has been analyzed the correlation of the number of years as a smoker, arterial hypertension and body mass index, against the risk of having calcified atheroma plaques. Study Design: Observational, transversal and prospective study with 84 patients from the Dental Center of Hospital Particular de Lisboa. First the patients answered to an inquiry and them…

medicine.medical_specialtyPathologyIsquèmia cerebralOrthopantomographyEarly detectionOdontologíaInternal medicineCarotid atheromamedicinecardiovascular diseasesProspective cohort studyGeneral DentistryStrokeArteritis de cèl·lules gegantsGiant cell arteritisCarotid diseaseOral Medicine and Pathologybusiness.industryResearchDental radiologyCerebral ischemiamedicine.disease:CIENCIAS MÉDICAS [UNESCO]Ciencias de la saludStrokeStenosisAtheromaCalcified atheromaUNESCO::CIENCIAS MÉDICASCardiologycardiovascular systemCalcified atheromabusinessRadiologia dentalBody mass indexJournal of clinical and experimental dentistry
researchProduct

Expression of Interleukin-32 in the Inflamed Arteries of Patients With Giant Cell Arteritis

2011

Objective Giant cell (temporal) arteritis (GCA) is a vasculitis that mainly affects the large and medium arteries, especially the branches of the proximal aorta. Interleukin-32 (IL-32) is a recently described Th1 proinflammatory cytokine, and is mainly induced by interferon-γ (IFNγ), IL-1β, and tumor necrosis factor α (TNFα). This study was undertaken to investigate the expression and tissue distribution of IL-32 in artery biopsy specimens from patients with GCA. Methods Quantitative gene expression analysis of IL-32, IL-1β, TNFα, IFNγ, IL-6, and IL-27 was performed in artery biopsy specimens obtained from 18 patients with GCA and 15 controls. Immunohistochemistry analysis was performed to …

MalePathologyInterleukin-1betaMessenger80 and overImmunology and AllergyPharmacology (medical)Giant Cell ArteritiAged 80 and overeducation.field_of_studyReverse Transcriptase Polymerase Chain ReactionInterleukin-17StatisticsArteriesMiddle AgedFlow CytometryImmunohistochemistryTh1 responseFemaleInterleukin 17VasculitisInterleukin-32; Giant Cell Arteritis; Th1 responsemedicine.medical_specialtyGiant Cell ArteritisImmunologyPopulationBiologyStatistics NonparametricProinflammatory cytokineInterferon-gammaRheumatologymedicine.arterymedicineHumansNonparametricRNA MessengerArteritiseducationAgedAortaAged; Aged 80 and over; Arteries; Female; Flow Cytometry; Giant Cell Arteritis; Humans; Immunohistochemistry; Interferon-gamma; Interleukin-17; Interleukin-1beta; Interleukin-6; Interleukins; Male; Middle Aged; RNA Messenger; Reverse Transcriptase Polymerase Chain Reaction; Statistics Nonparametric; Th1 Cells; Tumor Necrosis Factor-alphaInterleukin-6Tumor Necrosis Factor-alphaInterleukinsTh1 Cellsmedicine.diseaseInterleukin-32Giant cell arteritisGiant cellImmunologyRNA
researchProduct

Use of 18F-fluorodeoxyglucose positron emission tomography-computed tomography in patients affected by polymyalgia rheumatica and persistent increase…

2022

Polymyalgia rheumatica (PMR) is an inflammatory disease affecting older adults characterized by aching pain and morning stiffness of the shoulder and pelvic girdles. Moreover, PMR can be associated with giant cell arteritis (GCA). Generally, PMR is highly responsive to steroids, reaching complete remission in the majority of cases. However, the possibility of occult diseases, including extra-cranial GCA, should be excluded. 18F-fluorodeoxyglucose positron emission tomography (18F-FDG-PET) is able to detect the presence of peri-/articular or vascular inflammation, which may be both present in PMR, thus representing a useful diagnostic tool, mainly in presence of extra-cranial GCA. We retrosp…

arthritigiant cell arteritiPETarthritisgiant cell arteritisinflammationpolymyalgia rheumatica.General Medicinepolymyalgia rheumaticaFrontiers in Medicine
researchProduct

AN ATYPICAL CASE OF GIANT CELL ARTERITIS (HORTON'S DISEASE) ASSOCIATED WITH FACIAL SWELLING, CONFUSION, AND PERICARDITIS IN AN ELDERLY WOMAN

2010

Pathologymedicine.medical_specialtySystemic diseaseFacial swellingHeart diseaseVascular diseasebusiness.industryDiseasemedicine.diseasePericarditisGiant cell arteritismedicineGeriatrics and GerontologyVasculitisbusinessJournal of the American Geriatrics Society
researchProduct

Color Doppler Hemodynamics of Giant Cell Arteritis

1994

Objectives: To determine quantitative and qualitative hemodynamic alterations within the ophthalmic, central retinal, and short posterior ciliary arteries in patients with giant cell arteritis (GCA) proved by biopsy specimen. Design, Patients, and Setting: A consecutive case series of patients with GCA referred to an urban eye hospital who were evaluated with color Doppler imaging that was used to analyze orbital blood flow velocities and vascular resistance in 22 consecutive patients with GCA compared with age and sex-matched controls. Results: Patients with GCA all demonstrated significantly reduced central retinal and short posterior ciliary arterial mean flow velocities as well as signi…

MalePathologymedicine.medical_specialtyRetinal ArteryGiant Cell ArteritisHemodynamicsMethylprednisoloneOptic neuropathyOphthalmic Arterychemistry.chemical_compoundmedicine.arteryInternal medicineLaser-Doppler FlowmetrymedicineHumansAgedAged 80 and overVascular diseasebusiness.industryCiliary BodyRetinalShort posterior ciliary arteriesBlood flowLaser Doppler velocimetryMiddle Agedmedicine.diseaseOphthalmologyGiant cell arteritismedicine.anatomical_structurechemistryRegional Blood FlowOphthalmic arterycardiovascular systemVascular resistanceCardiologyFemaleNeurology (clinical)businessBlood Flow VelocityJournal of Neuro-Ophthalmology
researchProduct

New insights into the pathogenesis of giant cell arteritis

2017

Giant cell arteritis (GCA) is an inflammatory chronic disease occurring exclusively in elderly individuals. Until recently, the disease has been considered a unique disease resulting from the interaction in the walls of susceptible arteries, between an unknown infectious agents with local dendritic cells (DCs), activated CD4 T cells and effector macrophages. Recent evidence has shown that this view was too simplistic and has clarified many of the pathogenetic aspects of the disease. Many genetic studies recently published have identified different new genes, including cytokines, adhesion molecules and regulators of innate immunity, as crucial players in the development and progression of GC…

030203 arthritis & rheumatology0301 basic medicineImmunology and Allergy; ImmunologyInnate immune systemGiant Cell ArteritisImmunologyContext (language use)DiseaseBiologymedicine.diseasePathogenesisSettore MED/16 - Reumatologia03 medical and health sciencesGiant cell arteritis030104 developmental biology0302 clinical medicineImmune systemLymphatic systemAntigenImmunologymedicineAnimalsHumansImmunology and Allergyskin and connective tissue diseases
researchProduct